Product Information
ACYCLOVIR 200 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $0.0977 per EA under NDC 60505004206. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 28, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Apotex Corp.NDC
60505004206
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACYCLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA075677FDA Approved
9/28/2005
TE Code
AB
On Market Since
3/20/2006
Pharmacological Classes
Price Statistics
The NADAC for ACYCLOVIR 200 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0977 per EA |
|---|---|
| All-time high | $0.1264 (Feb 12, 2014) |
| All-time low | $0.0748 (Nov 20, 2024) |
| 52-week high | $0.1093 |
| 52-week low | $0.0973 |
| Median price | $0.1066 |
| Average price | $0.1069 |
| Largest weekly change | -25.7% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACYCLOVIR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACYCLOVIR 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 200 MG CAPSULE, manufactured by Apotex Corp., is $0.0977 per EA (NDC 60505004206), effective Sep 30, 2026.
How has the price of ACYCLOVIR 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACYCLOVIR 200 MG CAPSULE has declined 6.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACYCLOVIR 200 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ACYCLOVIR 200 MG CAPSULE has ranged from a low of $0.0748 (Nov 20, 2024) to a high of $0.1264 (Feb 12, 2014), with a median of $0.1066 per EA.
Are there cheaper alternatives to ACYCLOVIR 200 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACYCLOVIR 200 MG CAPSULE, is $0.0973 per EA — about 0% below ACYCLOVIR 200 MG CAPSULE.
Who manufactures ACYCLOVIR 200 MG CAPSULE?
ACYCLOVIR 200 MG CAPSULE (NDC 60505004206) is labeled by Apotex Corp., and CMS classifies it as a generic product.